Form: 8-K

Current report

May 8, 2024

Exhibit 99.1
emrprlogo2b.jpg
Emerson Reports Second Quarter 2024 Results; Updates 2024 Outlook
ST. LOUIS (May 8, 2024) - Emerson (NYSE: EMR) today reported results1 for its second quarter ended March 31, 2024 and updated its full year outlook for fiscal 2024. Emerson also declared a quarterly cash dividend of $0.525 per share of common stock payable June 10, 2024 to stockholders of record on May 17, 2024.
(dollars in millions, except per share) 2023 Q2 2024 Q2 Change
Underlying Orders2
(1)%
Net Sales $3,756 $4,376 17%
Underlying Sales3
8%
Pretax Earnings $639 $652
Margin 17.0% 14.9% (210) bps
Adjusted Segment EBITA4
$924 $1,139
Margin 24.6% 26.0% 140 bps
GAAP Earnings Per Share $0.92 $0.87 (5)%
Adjusted Earnings Per Share5
$1.09 $1.36 25%
Operating Cash Flow $575 $757 32%
Free Cash Flow $513 $675 32%
Management Commentary
“Emerson's outstanding execution continued in the second quarter, with sales growth, margin expansion and earnings all exceeding expectations,” said Emerson President and Chief Executive Officer Lal Karsanbhai. “Underlying orders met our low-single-digit growth expectations for the first half of fiscal 2024, supported by process and hybrid end markets. The strong performance and relentless focus on execution give us the confidence to update our full year 2024 outlook."

Karsanbhai continued, “Our second quarter performance, especially our gross margin performance, demonstrates the strength of our transformed portfolio and our Emerson Management System. We are well positioned to continue delivering differentiated solutions to our customers and creating value for our shareholders.”
2024 Outlook
The following tables summarize the fiscal year 2024 guidance framework. The 2024 outlook assumes approximately $500 million returned to shareholders through share repurchases and approximately $1.2 billion of dividend payments. Guidance figures are approximate.
2024 Q3 2024
Net Sales Growth 11% - 12.5% 15% - 16%
Underlying Sales Growth 3% - 4.5% 5.5% - 6.5%
Earnings Per Share $0.92 - $0.96 $2.98 - $3.08
Amortization of Intangibles ~$0.36 ~$1.43
Restructuring and Related Costs ~$0.07 ~$0.32
Loss on Copeland Equity Method Investment ~$0.02 ~$0.19
Amortization of Acquisition-related Inventory Step-up --- $0.38
Acquisition / Divestiture Fees and Related Costs ~$0.01 ~$0.23
Divestiture Loss / (Gain), net --- ($0.03)
Discrete Tax Benefits --- ($0.10)
Adjusted Earnings Per Share $1.38 - $1.42 $5.40 - $5.50
Operating Cash Flow ~$3.1B
Free Cash Flow ~$2.7B
1 Results are presented on a continuing operations basis.
2 Underlying orders does not include AspenTech.
3 Underlying sales excludes the impact of currency translation, and significant acquisitions and divestitures.
4 Adjusted segment EBITA represents segment earnings less restructuring and intangibles amortization expense.


Page 2
5 Adjusted EPS excludes intangibles amortization expense, restructuring and related costs, the income/loss of Emerson's 40% share of Copeland, the amortization of acquisition-related inventory step-up, acquisition/divestiture gains, losses, fees and related costs, discrete tax benefits, an AspenTech Micromine purchase price hedge and write-offs associated with Emerson's Russia exit.
Conference Call
Today, beginning at 8:00 a.m. Central Time / 9:00 a.m. Eastern Time, Emerson management will discuss the second quarter results during an investor conference call. Participants can access a live webcast available at www.emerson.com/investors at the time of the call. A replay of the call will be available for 90 days. Conference call slides will be posted in advance of the call on the company website.
About Emerson
Emerson (NYSE: EMR) is a global technology and software company providing innovative solutions for the world's essential industries. Through its leading automation portfolio, including its majority stake in AspenTech, Emerson helps hybrid, process and discrete manufacturers optimize operations, protect personnel, reduce emissions and achieve their sustainability goals. For more information, visit Emerson.com.
Forward-Looking and Cautionary Statements
Statements in this press release that are not strictly historical may be “forward-looking” statements, which involve risks and uncertainties, and Emerson undertakes no obligation to update any such statements to reflect later developments. These risks and uncertainties include the scope, duration and ultimate impacts of the Russia-Ukraine and other global conflicts, as well as economic and currency conditions, market demand, pricing, protection of intellectual property, cybersecurity, tariffs, competitive and technological factors, inflation, among others, as set forth in the Company's most recent Annual Report on Form 10-K and subsequent reports filed with the SEC. The outlook contained herein represents the Company's expectation for its consolidated results, other than as noted herein.
Emerson uses our Investor Relations website, www.Emerson.com/investors, as a means of disclosing information
which may be of interest or material to our investors and for complying with disclosure obligations under Regulation
FD. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases,
SEC filings, public conference calls, webcasts and social media. The information contained on, or that may be
accessed through, our website is not incorporated by reference into, and is not a part of, this document.
Investors: Media:
Colleen Mettler Joseph Sala / Greg Klassen
(314) 553-2197 Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449










(tables attached)


Page 3
Table 1
EMERSON AND SUBSIDIARIES
CONSOLIDATED OPERATING RESULTS
(AMOUNTS IN MILLIONS EXCEPT PER SHARE, UNAUDITED)
Quarter Ended March 31, Six Months Ended March 31,
2023 2024 2023 2024
Net sales $ 3,756  $ 4,376  $ 7,129  $ 8,493 
     Cost of sales 1,955  2,092  3,708  4,293 
     SG&A expenses 1,000  1,296  2,030  2,573 
     Gain on subordinated interest —  (79) —  (79)
     Other deductions, net 109  389  229  876 
     Interest expense, net 53  57  101  101 
     Interest income from related party1
—  (31) —  (62)
Earnings from continuing operations before income taxes 639  652  1,061  791 
Income taxes 134  149  232  156 
Earnings from continuing operations 505  503  829  635 
Discontinued operations, net of tax 265  —  2,267  — 
Net earnings 770  503  3,096  635 
Less: Noncontrolling interests in subsidiaries (22) (27) (8)
Net earnings common stockholders $ 792  $ 501  $ 3,123  $ 643 
Earnings common stockholders
Earnings from continuing operations $ 530  $ 501  $ 859  $ 643 
Discontinued operations 262  —  2,264  — 
Net earnings common stockholders $ 792  $ 501  $ 3,123  $ 643 
Diluted avg. shares outstanding 573.6  574.1  580.1  573.7 
Diluted earnings per share common stockholders
Earnings from continuing operations $0.92  $0.87  $1.48  $1.12 
Discontinued operations 0.46  —  3.90  — 
Diluted earnings per common share $1.38  $0.87  $5.38  $1.12 
Quarter Ended March 31, Six Months Ended March 31,
2023 2024 2023 2024
Other deductions, net
     Amortization of intangibles $119  $273  $237  $547 
     Restructuring costs 19  30  29  113 
     Other (29) 86  (37) 216 
          Total $109  $389  $229  $876 
1 Represents interest on the Copeland note receivable.


Page 4
Table 2
EMERSON AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(DOLLARS IN MILLIONS, UNAUDITED)
Sept 30, 2023 Mar 31, 2024
Assets
     Cash and equivalents $ 8,051  $ 2,318 
     Receivables, net 2,518  2,877 
     Inventories 2,006  2,357 
     Other current assets 1,244  1,457 
Total current assets 13,819  9,009 
     Property, plant & equipment, net 2,363  2,689 
     Goodwill 14,480  17,964 
     Other intangible assets 6,263  10,976 
     Copeland note receivable and equity investment 3,255  3,191 
     Other 2,566  2,611 
Total assets $ 42,746  $ 46,440 
Liabilities and equity
     Short-term borrowings and current maturities of long-term debt $ 547  $ 3,155 
     Accounts payable 1,275  1,271 
     Accrued expenses 3,210  3,238 
Total current liabilities 5,032  7,664 
     Long-term debt 7,610  7,614 
     Other liabilities 3,506  4,381 
Equity
     Common stockholders' equity 20,689  20,900 
     Noncontrolling interests in subsidiaries 5,909  5,881 
Total equity 26,598  26,781 
Total liabilities and equity $ 42,746  $ 46,440 


Page 5
Table 3
EMERSON AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(DOLLARS IN MILLIONS, UNAUDITED)
Six Months Ended March 31,
  2023 2024
Operating activities    
Net earnings $ 3,096  $ 635 
Earnings from discontinued operations, net of tax (2,267)
Adjustments to reconcile net earnings to net cash provided by operating activities:
        Depreciation and amortization 523 846
        Stock compensation 142 147
        Amortization of acquisition-related inventory step-up 231
        Gain on subordinated interest (79)
        Changes in operating working capital (390) (373)
        Other, net (227) (206)
            Cash from continuing operations 877 1,201
            Cash from discontinued operations (391) (43)
            Cash provided by operating activities 486 1,158
Investing activities
Capital expenditures (121) (159)
Purchases of businesses, net of cash and equivalents acquired (8,342)
Proceeds from subordinated interest 15  79 
Other, net (76) (68)
    Cash from continuing operations (182) (8,490)
    Cash from discontinued operations 2,916 1
    Cash provided by (used in) investing activities 2,734 (8,489)
Financing activities
Net increase (decrease) in short-term borrowings (31) 2,464
Proceeds from short-term borrowings greater than three months 395 99
Payments of long-term debt (742) (1)
Dividends paid (603) (600)
Purchases of common stock (2,000) (175)
AspenTech purchases of common stock (129)
Other, net (55) (45)
    Cash provided by (used in) financing activities (3,036) 1,613
Effect of exchange rate changes on cash and equivalents 58 (15)
Increase (decrease) in cash and equivalents 242 (5,733)
Beginning cash and equivalents 1,804 8,051
Ending cash and equivalents $ 2,046  $ 2,318 


Page 6
Table 4
EMERSON AND SUBSIDIARIES
SEGMENT SALES AND EARNINGS
(DOLLARS IN MILLIONS, UNAUDITED)
The following tables show results for the Company's segments on an adjusted segment EBITA basis and are intended to supplement the Company's results of operations, including its segment earnings which are defined as earnings before interest and taxes. The Company defines adjusted segment and total segment EBITA as segment earnings excluding intangibles amortization expense, and restructuring and related expense. Adjusted segment and total segment EBITA, and adjusted segment and total segment EBITA margin are measures used by management and may be useful for investors to evaluate the Company's segments' operational performance.
Quarter Ended March 31,
2023 2024 Reported Underlying
Sales
Final Control $ 992  $ 1,051  % %
Measurement & Analytical 888  1,013  14  % 16  %
Discrete Automation 683  632  (8) % (7) %
Safety & Productivity 361  365  % %
Intelligent Devices $ 2,924  $ 3,061  5  % 6  %
Control Systems & Software 623  687  11  % 12  %
Test & Measurement —  367  —  % —  %
AspenTech 230  278  21  % 21  %
Software and Control $ 853  $ 1,332  56  % 14  %
Eliminations (21) (17)
Total $ 3,756  $ 4,376  17  % 8  %



Sales Growth by Geography
Quarter Ended March 31,
Americas %
Europe 12  %
Asia, Middle East & Africa 11  %













Page 7

Table 4 cont.
Six Months Ended March 31,
2023 2024 Reported Underlying
Sales
Final Control $1,854  $1,991  % %
Measurement & Analytical 1,637  1,960  20  % 22  %
Discrete Automation 1,301  1,245  (4) % (5) %
Safety & Productivity 671  687  % %
Intelligent Devices $5,463  $5,883  8  % 8  %
Control Systems & Software 1,229  1,362  11  % 11  %
Test & Measurement —  749  —  % —  %
AspenTech 473  535  13  % 13  %
Software and Control $1,702  $2,646  56  % 12  %
Eliminations (36) (36)
Total $7,129  $8,493  19  % 9  %


Sales Growth by Geography
Six Months Ended March 31,
Americas %
Europe 11  %
Asia, Middle East & Africa 13  %


Page 8
Table 4 cont.
Quarter Ended March 31, Quarter Ended March 31,
2023 2024
As Reported (GAAP) Adjusted EBITA
(Non-GAAP)
As Reported (GAAP) Adjusted EBITA
(Non-GAAP)
Earnings
Final Control $ 215 $ 246 $ 259 $ 274
 Margins 21.6  % 24.7  % 24.7  % 26.1  %
Measurement & Analytical 229 234 274 287
 Margins 25.8  % 26.5  % 27.0  % 28.3  %
Discrete Automation 133 147 116 131
 Margins 19.5  % 21.5  % 18.4  % 20.9  %
Safety & Productivity 83 92 83 91
 Margins 22.9  % 25.2  % 22.7  % 24.7  %
Intelligent Devices $ 660 $ 719 $ 732 $ 783
 Margins 22.6  % 24.6  % 23.9  % 25.6  %
Control Systems & Software 127 137 151 165
 Margins 20.4  % 22.1  % 22.0  % 24.0  %
Test & Measurement —  —  (79) 78
 Margins —  % —  % (21.7) % 21.4  %
AspenTech (54) 68 (8) 113
 Margins (23.4) % 29.5  % (3.1) % 40.6  %
Software and Control $ 73 $ 205 $ 64 $ 356
 Margins 8.6  % 24.1  % 4.7  % 26.7  %
Corporate items and interest expense, net:
Stock compensation (40) (40) (73) (59)
Unallocated pension and postretirement costs 46  46  38  38 
Corporate and other (47) (55) (103) (46)
Gain on subordinated interest —  —  79  — 
Loss on Copeland equity method investment —  —  (59) — 
Interest expense, net (53) —  (57) — 
Interest income from related party1
—  —  31  — 
Pretax Earnings / Adjusted EBITA $ 639 $ 875 $ 652 $ 1,072
 Margins 17.0  % 23.3  % 14.9  % 24.5  %
Supplemental Total Segment Earnings:
Adjusted Total Segment EBITA $ 924 $ 1,139
 Margins 24.6  % 26.0  %
1 Represents interest on the Copeland note receivable.


Page 9
Table 4 cont.

Quarter Ended March 31, Quarter Ended March 31,
2023 2024
Amortization of
Intangibles1
Restructuring
and
Related Costs2
Amortization of
Intangibles1
Restructuring
and
Related Costs2
Final Control $ 22  $ $ 22  $ (7)
Measurement & Analytical 5 —  12
Discrete Automation 7 7 8 7
Safety & Productivity 7 7
Intelligent Devices $ 41  $ 18  $ 49  $ 2 
Control Systems & Software 5 11 3
Test & Measurement —  141 16 
AspenTech 122 —  121 — 
Software and Control $ 127  $ 5  $ 273  $ 19 
Corporate —  3 —  12 3
Total $ 168  $ 26  $ 322  $ 33 
1 Amortization of intangibles includes $49 and $49 reported in cost of sales for the three months ended March 31, 2023 and 2024, respectively.
2 Restructuring and related costs includes $7 and $3 reported in cost of sales and selling, general and administrative expenses for the three months ended March 31, 2023 and 2024, respectively.
3 Corporate restructuring of $12 for the three months ended March 31, 2024 includes $10 related to integration-related stock compensation expense attributable to NI.
Quarter Ended March 31,
Depreciation and Amortization 2023 2024
Final Control $ 45  $ 39 
Measurement & Analytical 28  33 
Discrete Automation 22  21 
Safety & Productivity 15  15 
Intelligent Devices 110  108 
Control Systems & Software 24  28 
Test & Measurement —  153 
AspenTech 123  124 
Software and Control 147  305 
Corporate 11 
Total $ 263  $ 424 






Page 10
Table 5
EMERSON AND SUBSIDIARIES
ADJUSTED CORPORATE AND OTHER SUPPLEMENTAL
(DOLLARS IN MILLIONS, UNAUDITED)
The following table shows the Company's stock compensation and corporate and other expenses on an adjusted basis. The Company's definition of adjusted stock compensation excludes integration-related stock compensation expense. The Company's definition of adjusted corporate and other excludes corporate restructuring and related costs, first year purchase accounting related items and transaction fees, and certain gains, losses or impairments. This metric is useful for reconciling from total adjusted segment EBITA to the Company's consolidated adjusted EBITA.

Quarter Ended March 31,
2023 2024
 Stock compensation (GAAP) $ (40) $ (73)
 Integration-related stock compensation expense 14 1
 Adjusted stock compensation (non-GAAP) $ (40) $ (59)
Quarter Ended March 31,
2023 2024
 Corporate and other (GAAP) $ (47) $ (103)
 Corporate restructuring and related costs 3 2
 Acquisition / divestiture costs 10 16 
 National Instruments investment gain (35) — 
 Loss on divestiture of business 39 
 AspenTech Micromine purchase price hedge 14 
 Adjusted corporate and other (non-GAAP) $ (55) $ (46)
1 Integration-related stock compensation expense relates to NI and includes $10 reported as restructuring costs.




Page 11
Table 6
EMERSON AND SUBSIDIARIES
ADJUSTED EBITA & EPS SUPPLEMENTAL
(AMOUNTS IN MILLIONS EXCEPT PER SHARE, UNAUDITED)
The following tables, which show results on an adjusted EBITA basis and diluted earnings per share on an adjusted basis, are intended to supplement the Company's discussion of its results of operations herein. The Company defines adjusted EBITA as earnings excluding interest expense, net, income taxes, intangibles amortization expense, restructuring expense, first year purchase accounting related items and transaction fees, gains or losses on the Copeland equity method investment, and certain gains, losses or impairments. Adjusted earnings per share excludes intangibles amortization expense, restructuring expense, first year purchase accounting related items and transaction-related costs, gains or losses on the Copeland equity method investment, and certain gains, losses or impairments. Adjusted EBITA, adjusted EBITA margin, and adjusted earnings per share are measures used by management and may be useful for investors to evaluate the Company's operational performance.
Quarter Ended March 31,
2023 2024
Pretax earnings $ 639 $ 652
Percent of sales 17.0  % 14.9  %
Interest expense, net 53 57
Interest income from related party1
(31)
Amortization of intangibles 168 322
Restructuring and related costs 26 33
Acquisition/divestiture fees and related costs 10 20
Loss on divestiture of business 39
Gain on subordinated interest (79)
National Instruments investment gain (35)
AspenTech Micromine purchase price hedge 14
Loss on Copeland equity method investment 59
Adjusted EBITA $ 875 $ 1,072
Percent of sales 23.3  % 24.5  %
Quarter Ended March 31,
2023 2024
GAAP earnings from continuing operations per share $ 0.92 $ 0.87
Amortization of intangibles 0.16 0.36
Restructuring and related costs 0.04 0.05
Acquisition/divestiture fees and related costs 0.01 0.03
Loss on divestiture of business 0.07
Gain on subordinated interest (0.10)
National Instruments investment gain (0.05)
AspenTech Micromine purchase price hedge 0.01
Loss on Copeland equity method investment 0.08
Adjusted earnings from continuing operations per share $ 1.09 $ 1.36
Less: AspenTech contribution to adjusted earnings per share (0.04) (0.10)
Adjusted earnings per share excluding AspenTech contribution $ 1.05 $ 1.26
1 Represents interest on the Copeland note receivable


Page 12
Table 6 cont.
Quarter Ended March 31, 2024
Pretax
Earnings
Income
Taxes
Earnings from
Cont.
Ops.
Non-Controlling
Interests3
Net
Earnings
Common
Stockholders
Diluted
Earnings
Per
Share
As reported (GAAP) $ 652  $ 149  $ 503  $ 2  $ 501  $ 0.87 
Amortization of intangibles 322
1
72 250 41 209 0.36
Restructuring and related costs 33
2
5 28 —  28 0.05
Acquisition/divestiture fees and related costs 20 4 16 —  16 0.03
Loss on Copeland equity method investment 59 13 46 —  46 0.08
Loss on divestiture of business 39 (2) 41 —  41 0.07
Gain on subordinated interest (79) (19) (60) —  (60) (0.10)
Adjusted (non-GAAP) $ 1,046  $ 222  $ 824  $ 43  $ 781  $ 1.36 
Interest expense, net 57 
Interest income from related party4
(31)
Adjusted EBITA (non-GAAP) $ 1,072 
1 Amortization of intangibles includes $49 reported in cost of sales.
2 Restructuring and related costs includes $3 reported in cost of sales and and selling, general and administrative expenses.
3 Represents the non-controlling interest in AspenTech applied to AspenTech's share of each adjustment presented herein and eliminated from Emerson's consolidated results.
4 Represents interest on the Copeland note receivable.



Page 13
Table 7
EMERSON AND SUBSIDIARIES
ASPENTECH CONTRIBUTION TO EMERSON RESULTS SUPPLEMENTAL
(AMOUNTS IN MILLIONS EXCEPT PER SHARE, UNAUDITED)
The following tables reconcile the financial results of AspenTech reported to its shareholders with the amounts included in Emerson's consolidated financial results. Emerson currently owns approximately 57 percent of the common shares outstanding of AspenTech, a separately traded public company (NASDAQ: AZPN), and consolidates AspenTech in its financial results. The 43 percent non-controlling interest in AspenTech is removed from Emerson's net earnings common stockholders through the non-controlling interest line item. AspenTech is also one of Emerson's segments and its GAAP segment earnings is reconciled below to its consolidated impact to clarify that certain items are reported outside of its segment earnings within Emerson corporate, including interest income and stock compensation.

Quarter Ended March 31, 2024
Pretax
Earnings
Income
Taxes
(Benefit)
Earnings from
Cont.
Ops.
Non-Controlling
Interests4
Net
Earnings
Common
Stockholders
Diluted
Earnings
Per
Share
Standalone reporting (GAAP) $ (7) 1 $ (9) $ 2 
 Other —  (1) 1
Reported in Emerson consolidation (GAAP) (7) (10) 3 1  2 $  
Adjustments:
Amortization of intangibles 121  2 26

95  41 54 0.10
Adjusted (Non-GAAP) $ 114  $ 16  $ 98  $ 42  $ 56  $ 0.10 
 Interest income (14) 3
 Stock compensation 13 3
Adjusted segment EBITA (non-GAAP) $ 113 
Reconciliation to Segment EBIT
Pre-tax earnings $ (7)
Interest income (14) 3
Stock compensation 13 3
Segment EBIT (GAAP) $ (8)
Amortization of intangibles 121 2
Adjusted segment EBITA (non-GAAP) $ 113 
1 Amount reflects AspenTech's pretax earnings for the three months ended March 31, 2024 as reported in its quarterly earnings release 8-K.
2 Amortization of intangibles includes $49 reported in cost of sales.
3 Reported in Emerson corporate line items.
4 Represents the non-controlling interest in AspenTech applied to each adjustment presented herein and eliminated from Emerson's consolidated results.


Page 14
Reconciliations of Non-GAAP Financial Measures & Other Table 8
Reconciliations of Non-GAAP measures with the most directly comparable GAAP measure (dollars in millions, except per share amounts). See tables 4 through 7 for additional non-GAAP reconciliations.
2024 Q2 Underlying Sales Change Reported (Favorable) / Unfavorable FX (Acquisitions) /
Divestitures
Underlying
Final Control % % —  % %
Measurement & Analytical 14  % % % 16  %
Discrete Automation (8) % % —  % (7) %
Safety & Productivity % —  % —  % %
Intelligent Devices 5  % 1  %   % 6  %
Control Systems & Software 11  % % —  % 12  %
Test & Measurement —  % —  % —  % —  %
AspenTech 21  % —  % —  % 21  %
Software and Control 56  % 1  % (43) % 14  %
Emerson 17  % 1  % (10) % 8  %
Six Months Ended March 31, 2024 Underlying Sales Change Reported (Favorable) / Unfavorable FX (Acquisitions) /
Divestitures
Underlying
Final Control % —  % % %
Measurement & Analytical 20  % —  % % 22  %
Discrete Automation (4) % (1) % —  % (5) %
Safety & Productivity % —  % —  % %
Intelligent Devices 8  %   %   % 8  %
Control Systems & Software 11  % —  % —  % 11  %
Test & Measurement —  % —  % —  % —  %
AspenTech 13  % —  % —  % 13  %
Software and Control 56  %   % (44) % 12  %
Emerson 19  %   % (10) % 9  %
Underlying Growth Guidance 2024 Q3 Guidance 2024
Guidance
Reported (GAAP) 11% - 12.5% 15% - 16%
(Favorable) / Unfavorable FX ~ 1 pts ~ 0.5 pts
(Acquisitions) / Divestitures ~(9) pts ~ (10) pts
Underlying (non-GAAP) 3% - 4.5% 5.5% - 6.5%



Page 15
2023 Q2 Adjusted Segment EBITA EBIT EBIT
Margin
Amortization
of
Intangibles
Restructuring and Related Costs Adjusted Segment EBITA Adjusted Segment EBITA Margin
Final Control $ 215  21.6  % $ 22  $ $ 246  24.7  %
Measurement & Analytical 229  25.8  % —  234  26.5  %
Discrete Automation 133  19.5  % 147  21.5  %
Safety & Productivity 83  22.9  % 92  25.2  %
Intelligent Devices $ 660  22.6  % $ 41  $ 18  $ 719  24.6  %
Control Systems & Software 127  20.4  % 137  22.1  %
Test & Measurement —  —  % —  —  —  —  %
AspenTech (54) (23.4) % 122  —  68  29.5  %
Software and Control $ 73  8.6  % $ 127  $ 5  $ 205  24.1  %
2024 Q2 Adjusted Segment EBITA EBIT EBIT
Margin
Amortization
of
Intangibles
Restructuring and Related Costs Adjusted Segment EBITA Adjusted Segment EBITA Margin
Final Control $ 259  24.7  % $ 22  $ (7) $ 274  26.1  %
Measurement & Analytical 274  27.0  % 12  287  28.3  %
Discrete Automation 116  18.4  % 131  20.9  %
Safety & Productivity 83  22.7  % 91  24.7  %
Intelligent Devices $ 732  23.9  % $ 49  $ 2  $ 783  25.6  %
Control Systems & Software 151  22.0  % 11  165  24.0  %
Test & Measurement (79) (21.7) % 141  16  78  21.4  %
AspenTech (8) (3.1) % 121  —  113  40.6  %
Software and Control $ 64  4.7  % $ 273  $ 19  $ 356  26.7  %

Total Adjusted Segment EBITA 2023 Q2 2024 Q2
Pretax earnings (GAAP) $ 639 $ 652
Margin 17.0  % 14.9  %
Corporate items and interest expense, net 94 144
Amortization of intangibles 168 322
Restructuring and related costs 23 21
Adjusted segment EBITA (non-GAAP) $ 924 $ 1,139
Margin 24.6  % 26.0  %


Free Cash Flow 2023 Q2 2024 Q2 2024E
($ in billions)
Operating cash flow (GAAP) $ 575  $ 757   ~ $ 3.1
Capital expenditures (62) (82) ~(0.4)
Free cash flow (non-GAAP) $ 513  $ 675  ~ $2.7

Note 1: Underlying sales and orders exclude the impact of currency translation and significant acquisitions and divestitures.
Note 2: All fiscal year 2024E figures are approximate, except where range is given.